Achromobacter Spp: Description of Epidemiology and Resistance in Chronic Ear Infections and in Healthy Individuals.

Centre Hospitalier Universitaire Dijon1,800 enrolled

Overview

Hearing loss can be the result of chronic ear infections. The role of bacteria of the genus Achromobacter is not known in these conditions. An epidemiological study including a large number of patients is needed to compare the prevalence of these bacteria in sick and healthy subjects, and to highlight the characteristics of the strains and the factors favouring their emergence.

Study Type

OBSERVATIONAL

Enrollment

1,800

Conditions

Achromobacter Epidemiology Chronic Ear Infection

Interventions

Ear canal swabBIOLOGICAL

Ear canal swab

Eligibility

Sex: ALLMin age: 10 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Person or parent who has given his or her non-opposition * Person over 10 years of age * Sick Subjects Group : diagnosis of chronic infection by an ENT specialist doctor if patient already included: new episode \> 3 months after the complete clinical recovery from the previous episode observed by the ENT doctor - Healthy group: no ear infection in the last 6 months and no antibiotics in the previous month. Exclusion Criteria: \-

Locations (1)

Chu Dijon Bourgogne

Dijon, France

Outcomes

Primary Outcomes

Achromobacter positive sample number

Time frame: Through study completion, an average of 3 years

Central Contacts

Lucie AMOUREUX

CONTACT

03.80.29.56.86 lucie.amoureux@chu-dijon.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.